CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 192 of 865
Non-Antibody Products
Page 192 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| C22 Phytoceramide-d3 (t18:0/22:0-d3) | An internal standard for the quantification of C22 phytoceramide by GC- or… | 1 mg | 9003465-1 | More Info |
| C22 Phytoceramide-d3 (t18:0/22:0-d3) | An internal standard for the quantification of C22 phytoceramide by GC- or… | 500 µg | 9003465-500 | More Info |
| C16 Phytoceramide (t18:0/16:0) | A phytoceramide; levels increase following heat stress in S. cerevisiae; u… | 5 mg | 22826-5 | More Info |
| C18 Phytoceramide (t18:0/18:0) | A bioactive sphingolipid found in S. cerevisiae, wheat grains, and mammali… | 5 mg | 22686-5 | More Info |
| C2 Phytoceramide (t18:0/2:0) | A bioactive sphingolipid; inhibits formyl peptide-induced oxidant release… | 5 mg | 22823-5 | More Info |
| C22 Phytoceramide (t18:0/22:0) | A sphingolipid; has been found in Moro blood orange (C. sinensis) peels an… | 1 mg | 9003464-1 | More Info |
| C22 Phytoceramide (t18:0/22:0) | A sphingolipid; has been found in Moro blood orange (C. sinensis) peels an… | 5 mg | 9003464-5 | More Info |
| C24 Phytoceramide (t18:0/24:0) | A sphingolipid and phytoceramide; used with other ceramides to create stra… | 1 mg | 22827-1 | More Info |
| C24 Phytoceramide (t18:0/24:0) | A sphingolipid and phytoceramide; used with other ceramides to create stra… | 5 mg | 22827-5 | More Info |
| C6 Phytoceramide (t18:0/6:0) | A bioactive sphingolipid and cell-permeable analog of phytoceramide; induc… | 5 mg | 24438-5 | More Info |
| C8 Phytoceramide (t18:0/8:0) | A sphingolipid; a cell-permeable analog of phytosphingosine | 5 mg | 24357-5 | More Info |
| CPI-1189 | A benzamide; inhibits phosphorylation of p38 MAPK in IL-1β-stimulated… | 100 mg | 29187-100 | More Info |
| CPI-1189 | A benzamide; inhibits phosphorylation of p38 MAPK in IL-1β-stimulated… | 25 mg | 29187-25 | More Info |
| CPI-1189 | A benzamide; inhibits phosphorylation of p38 MAPK in IL-1β-stimulated… | 250 mg | 29187-250 | More Info |
| CPI-1189 | A benzamide; inhibits phosphorylation of p38 MAPK in IL-1β-stimulated… | 50 mg | 29187-50 | More Info |
| CPI-169 | A selective EZH2 inhibitor (IC50s = 0.24, 0.51, and 6.1 nM for wild-type E… | 1 mg | 18299-1 | More Info |
| CPI-169 | A selective EZH2 inhibitor (IC50s = 0.24, 0.51, and 6.1 nM for wild-type E… | 5 mg | 18299-5 | More Info |
| CPI-203 | A primary amide analog of (+)-JQ1 which has shown superior bioavailability… | 1 mg | 15479-1 | More Info |
| CPI-203 | A primary amide analog of (+)-JQ1 which has shown superior bioavailability… | 10 mg | 15479-10 | More Info |
| CPI-203 | A primary amide analog of (+)-JQ1 which has shown superior bioavailability… | 25 mg | 15479-25 | More Info |
| CPI-203 | A primary amide analog of (+)-JQ1 which has shown superior bioavailability… | 5 mg | 15479-5 | More Info |
| CPI-268456 | A ligand of BRD4; binds to BRD4 (IC50 = 50 = <0.5 µM) | 1 mg | 20973-1 | More Info |
| CPI-268456 | A ligand of BRD4; binds to BRD4 (IC50 = 50 = <0.5 µM) | 10 mg | 20973-10 | More Info |
| CPI-268456 | A ligand of BRD4; binds to BRD4 (IC50 = 50 = <0.5 µM) | 25 mg | 20973-25 | More Info |
| CPI-268456 | A ligand of BRD4; binds to BRD4 (IC50 = 50 = <0.5 µM) | 5 mg | 20973-5 | More Info |
| CPI-360 | A selective EZH2 inhibitor (IC50s = 0.5 and 2.5 nM for wild-type EZH2 and… | 1 mg | 19125-1 | More Info |
| CPI-360 | A selective EZH2 inhibitor (IC50s = 0.5 and 2.5 nM for wild-type EZH2 and… | 10 mg | 19125-10 | More Info |
| CPI-360 | A selective EZH2 inhibitor (IC50s = 0.5 and 2.5 nM for wild-type EZH2 and… | 5 mg | 19125-5 | More Info |
| CPI-360 | A selective EZH2 inhibitor (IC50s = 0.5 and 2.5 nM for wild-type EZH2 and… | 500 µg | 19125-500 | More Info |
| CPI-444 | An adenosine A2A receptor antagonist; reduces tumor area in a mouse model… | 1 mg | 25024-1 | More Info |
| CPI-444 | An adenosine A2A receptor antagonist; reduces tumor area in a mouse model… | 10 mg | 25024-10 | More Info |
| CPI-444 | An adenosine A2A receptor antagonist; reduces tumor area in a mouse model… | 25 mg | 25024-25 | More Info |
| CPI-444 | An adenosine A2A receptor antagonist; reduces tumor area in a mouse model… | 5 mg | 25024-5 | More Info |
| CPI-455 | A KDM5 inhibitor; selectively inhibits KDM5A-D (IC50s = 2-10 nM) over KDM2… | 1 mg | 22127-1 | More Info |
| CPI-455 | A KDM5 inhibitor; selectively inhibits KDM5A-D (IC50s = 2-10 nM) over KDM2… | 10 mg | 22127-10 | More Info |
| CPI-455 | A KDM5 inhibitor; selectively inhibits KDM5A-D (IC50s = 2-10 nM) over KDM2… | 25 mg | 22127-25 | More Info |
| CPI-455 | A KDM5 inhibitor; selectively inhibits KDM5A-D (IC50s = 2-10 nM) over KDM2… | 5 mg | 22127-5 | More Info |
| CPI-613 | A lipoic acid analog that inhibits α-ketoglutarate dehydrogenase, pa… | 10 mg | 16981-10 | More Info |
| CPI-613 | A lipoic acid analog that inhibits α-ketoglutarate dehydrogenase, pa… | 25 mg | 16981-25 | More Info |
| CPI-613 | A lipoic acid analog that inhibits α-ketoglutarate dehydrogenase, pa… | 5 mg | 16981-5 | More Info |
| CPI-613 | A lipoic acid analog that inhibits α-ketoglutarate dehydrogenase, pa… | 50 mg | 16981-50 | More Info |
| CPI-637 | An inhibitor of CBP / EP300 bromodomains (IC50s = 30 and 51 nM in a TR-FRE… | 1 mg | 23500-1 | More Info |
| CPI-637 | An inhibitor of CBP / EP300 bromodomains (IC50s = 30 and 51 nM in a TR-FRE… | 10 mg | 23500-10 | More Info |
| CPI-637 | An inhibitor of CBP / EP300 bromodomains (IC50s = 30 and 51 nM in a TR-FRE… | 25 mg | 23500-25 | More Info |
| CPI-637 | An inhibitor of CBP / EP300 bromodomains (IC50s = 30 and 51 nM in a TR-FRE… | 5 mg | 23500-5 | More Info |
| cPLA2 Assay Kit | Arachidonoyl thio-PC is a substrate for cPLA2 by virtue of the presence of… | 96 Well | 765021-96WELLS | More Info |
| C18 ((±)-2'-hydroxy) Ceramide (d18:1/18:0) | A bioactive lipid found in the stratum corneum layer of mammalian epidermi… | 5 mg | 22687-5 | More Info |
| C12((±)-2'-hydroxy) dihydro Ceramide (d18:0/12:0) | A 2'-hydroxylated form of C12 dihydro ceramide, | 5 mg | 24435-5 | More Info |
| C16((±)-2'-hydroxy) dihydro Ceramide (d18:0/16:0) | A 2'-hydroxylated form of C16 dihydro ceramide, | 5 mg | 24436-5 | More Info |
| C18 ((±)-2'-hydroxy) dihydro Ceramide (d18:0/18:0) | A 2'-hydroxylated form of C18 dihydro ceramide | 5 mg | 24437-5 | More Info |
| CP-392,110 (maleate) | An AMPA receptor antagonist; inhibits AMPA receptor-mediated calcium uptak… | 1 mg | 20473-1 | More Info |
| CP-392,110 (maleate) | An AMPA receptor antagonist; inhibits AMPA receptor-mediated calcium uptak… | 10 mg | 20473-10 | More Info |
| CP-392,110 (maleate) | An AMPA receptor antagonist; inhibits AMPA receptor-mediated calcium uptak… | 5 mg | 20473-5 | More Info |
| 1cP-MiPLA (solution) | An analytical reference standard categorized as a lysergamide; intended fo… | 100 µg | 39013-100 | More Info |
| CPPA-TPP | A TPP-conjugated chain transfer agent; has been used in the synthesis of r… | 1 mg | 40439-1 | More Info |
| CPPA-TPP | A TPP-conjugated chain transfer agent; has been used in the synthesis of r… | 10 mg | 40439-10 | More Info |
| CPPA-TPP | A TPP-conjugated chain transfer agent; has been used in the synthesis of r… | 5 mg | 40439-5 | More Info |
| 4-CPPC | A MIF-2 inhibitor (IC50 = 27 µM); selective for MIF-2 over MIF-1 (IC… | 1 mg | 30068-1 | More Info |
| 4-CPPC | A MIF-2 inhibitor (IC50 = 27 µM); selective for MIF-2 over MIF-1 (IC… | 10 mg | 30068-10 | More Info |
| 4-CPPC | A MIF-2 inhibitor (IC50 = 27 µM); selective for MIF-2 over MIF-1 (IC… | 5 mg | 30068-5 | More Info |
| 4-CPPC | A MIF-2 inhibitor (IC50 = 27 µM); selective for MIF-2 over MIF-1 (IC… | 500 µg | 30068-500 | More Info |
| 13C6-6-PPD-quinone | An internal standard for the quantification of 6-PPD-quinone by GC- or LC-… | 1 mg | 40606-1 | More Info |
| 13C6-6-PPD-quinone | An internal standard for the quantification of 6-PPD-quinone by GC- or LC-… | 5 mg | 40606-5 | More Info |
| 13C6-6-PPD-quinone | An internal standard for the quantification of 6-PPD-quinone by GC- or LC-… | 500 µg | 40606-500 | More Info |
| CPPG | An antagonist of group II and group III mGluRs; It reverses inhibition of… | 1 mg | 34362-1 | More Info |
| CPPG | An antagonist of group II and group III mGluRs; It reverses inhibition of… | 10 mg | 34362-10 | More Info |
| CPPG | An antagonist of group II and group III mGluRs; It reverses inhibition of… | 25 mg | 34362-25 | More Info |
| CPPG | An antagonist of group II and group III mGluRs; It reverses inhibition of… | 5 mg | 34362-5 | More Info |
| CPPHA | A positive allosteric modulator of the mGluR5; potentiates human and rat m… | 1 mg | 21275-1 | More Info |
| CPPHA | A positive allosteric modulator of the mGluR5; potentiates human and rat m… | 10 mg | 21275-10 | More Info |
| CPPHA | A positive allosteric modulator of the mGluR5; potentiates human and rat m… | 25 mg | 21275-25 | More Info |
| CPPHA | A positive allosteric modulator of the mGluR5; potentiates human and rat m… | 5 mg | 21275-5 | More Info |
| [cPP1-7,NPY19-23,Ala31,Aib32,Gln34] - Pancreatic Polypeptide (human) (acetate) | An agonist of NPY receptor Y5; inhibits forskolin-induced cAMP production… | 1 mg | 36718-1 | More Info |
| [cPP1-7,NPY19-23,Ala31,Aib32,Gln34] - Pancreatic Polypeptide (human) (acetate) | An agonist of NPY receptor Y5; inhibits forskolin-induced cAMP production… | 10 mg | 36718-10 | More Info |
| [cPP1-7,NPY19-23,Ala31,Aib32,Gln34] - Pancreatic Polypeptide (human) (acetate) | An agonist of NPY receptor Y5; inhibits forskolin-induced cAMP production… | 5 mg | 36718-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile